Choulwar Amol K. (2013). Phase-III Clinical and Bioequivalence Study to Evaluate Efficacy and safety of Antihyperparathyroidism and Antianginal D. NMIMS-SPPSPTM.
Chicago-referens (17:e uppl.)Choulwar Amol K. Phase-III Clinical and Bioequivalence Study to Evaluate Efficacy and Safety of Antihyperparathyroidism and Antianginal D. Mumbai: NMIMS-SPPSPTM, 2013.
MLA-referens (9:e uppl.)Choulwar Amol K. Phase-III Clinical and Bioequivalence Study to Evaluate Efficacy and Safety of Antihyperparathyroidism and Antianginal D. NMIMS-SPPSPTM, 2013.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.